FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2995804539> ?p ?o ?g. }

• W2995804539 abstract "Background Heart failure is one of the leading causes of death in Western countries, and there is a need for new therapeutic approaches. Relaxin‐2 is a peptide hormone that mediates pleiotropic cardiovascular effects, including antifibrotic, angiogenic, vasodilatory, antiapoptotic, and anti‐inflammatory effects in vitro and in vivo. Methods and Results We developed RELAX 10, a fusion protein composed of human relaxin‐2 hormone and the Fc of a human antibody, to test the hypothesis that extended exposure of the relaxin‐2 peptide could reduce cardiac hypertrophy and fibrosis. RELAX 10 demonstrated the same specificity and similar in vitro activity as the relaxin‐2 peptide. The terminal half‐life of RELAX 10 was 7 days in mouse and 3.75 days in rat after subcutaneous administration. We evaluated whether treatment with RELAX 10 could prevent and reverse isoproterenol‐induced cardiac hypertrophy and fibrosis in mice. Isoproterenol administration in mice resulted in increased cardiac hypertrophy and fibrosis compared with vehicle. Coadministration with RELAX 10 significantly attenuated the cardiac hypertrophy and fibrosis compared with untreated animals. Isoproterenol administration significantly increased transforming growth factor β1 (TGF‐β1)–induced fibrotic signaling, which was attenuated by RELAX 10. We found that RELAX 10 also significantly increased protein kinase B/endothelial NO synthase signaling and protein S‐nitrosylation. In the reversal study, RELAX 10‐treated animals showed significantly reduced cardiac hypertrophy and collagen levels. Conclusions These findings support a potential role for RELAX 10 in the treatment of heart failure." @default.
• W2995804539 created "2019-12-26" @default.
• W2995804539 creator A5012506757 @default.
• W2995804539 creator A5017885167 @default.
• W2995804539 creator A5026294003 @default.
• W2995804539 creator A5027972181 @default.
• W2995804539 creator A5029146873 @default.
• W2995804539 creator A5030676667 @default.
• W2995804539 creator A5032599900 @default.
• W2995804539 creator A5036949718 @default.
• W2995804539 creator A5041720748 @default.
• W2995804539 creator A5042806799 @default.
• W2995804539 creator A5046930203 @default.
• W2995804539 creator A5052765300 @default.
• W2995804539 creator A5053339178 @default.
• W2995804539 creator A5064257229 @default.
• W2995804539 creator A5074084393 @default.
• W2995804539 creator A5079547126 @default.
• W2995804539 creator A5089124744 @default.
• W2995804539 date "2019-12-17" @default.
• W2995804539 modified "2023-10-18" @default.
• W2995804539 title "Human Relaxin‐2 Fusion Protein Treatment Prevents and Reverses Isoproterenol‐Induced Hypertrophy and Fibrosis in Mouse Heart" @default.
• W2995804539 cites W103364344 @default.
• W2995804539 cites W1495512620 @default.
• W2995804539 cites W1573768413 @default.
• W2995804539 cites W1607892649 @default.
• W2995804539 cites W1619234695 @default.
• W2995804539 cites W1982570312 @default.
• W2995804539 cites W1984606464 @default.
• W2995804539 cites W1992254322 @default.
• W2995804539 cites W2004575445 @default.
• W2995804539 cites W2005539486 @default.
• W2995804539 cites W2011130900 @default.
• W2995804539 cites W2012124023 @default.
• W2995804539 cites W2017180750 @default.
• W2995804539 cites W2018492901 @default.
• W2995804539 cites W2029609182 @default.
• W2995804539 cites W2033955551 @default.
• W2995804539 cites W2041479810 @default.
• W2995804539 cites W2041698827 @default.
• W2995804539 cites W2047688401 @default.
• W2995804539 cites W2047972447 @default.
• W2995804539 cites W2066231048 @default.
• W2995804539 cites W2077033733 @default.
• W2995804539 cites W2083891358 @default.
• W2995804539 cites W2085522770 @default.
• W2995804539 cites W2087168695 @default.
• W2995804539 cites W2088759134 @default.
• W2995804539 cites W2091174988 @default.
• W2995804539 cites W2096133307 @default.
• W2995804539 cites W2109306328 @default.
• W2995804539 cites W2109649607 @default.
• W2995804539 cites W2113837947 @default.
• W2995804539 cites W2118555638 @default.
• W2995804539 cites W2125931795 @default.
• W2995804539 cites W2126788226 @default.
• W2995804539 cites W2136917811 @default.
• W2995804539 cites W2139478233 @default.
• W2995804539 cites W2143004446 @default.
• W2995804539 cites W2148841809 @default.
• W2995804539 cites W2151825176 @default.
• W2995804539 cites W2152865365 @default.
• W2995804539 cites W2154948505 @default.
• W2995804539 cites W2160489474 @default.
• W2995804539 cites W2306834116 @default.
• W2995804539 cites W2333021297 @default.
• W2995804539 cites W2409541478 @default.
• W2995804539 cites W2516453631 @default.
• W2995804539 cites W2530905492 @default.
• W2995804539 cites W2564154584 @default.
• W2995804539 cites W2609501679 @default.
• W2995804539 cites W2789782807 @default.
• W2995804539 cites W2793698856 @default.
• W2995804539 cites W2843170412 @default.
• W2995804539 cites W4293084779 @default.
• W2995804539 doi "https://doi.org/10.1161/jaha.119.013465" @default.
• W2995804539 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6951077" @default.
• W2995804539 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31818212" @default.
• W2995804539 hasPublicationYear "2019" @default.
• W2995804539 type Work @default.
• W2995804539 sameAs 2995804539 @default.
• W2995804539 citedByCount "8" @default.
• W2995804539 countsByYear W29958045392020 @default.
• W2995804539 countsByYear W29958045392021 @default.
• W2995804539 countsByYear W29958045392022 @default.
• W2995804539 countsByYear W29958045392023 @default.
• W2995804539 crossrefType "journal-article" @default.
• W2995804539 hasAuthorship W2995804539A5012506757 @default.
• W2995804539 hasAuthorship W2995804539A5017885167 @default.
• W2995804539 hasAuthorship W2995804539A5026294003 @default.
• W2995804539 hasAuthorship W2995804539A5027972181 @default.
• W2995804539 hasAuthorship W2995804539A5029146873 @default.
• W2995804539 hasAuthorship W2995804539A5030676667 @default.
• W2995804539 hasAuthorship W2995804539A5032599900 @default.
• W2995804539 hasAuthorship W2995804539A5036949718 @default.
• W2995804539 hasAuthorship W2995804539A5041720748 @default.
• W2995804539 hasAuthorship W2995804539A5042806799 @default.
• W2995804539 hasAuthorship W2995804539A5046930203 @default.
• W2995804539 hasAuthorship W2995804539A5052765300 @default.
• W2995804539 hasAuthorship W2995804539A5053339178 @default.

• next